In this study, we investigated the role of the C1orf50 gene, whose function was previously unknown in breast cancer progression, and confirmed that the prognosis is significantly worse in the group with high C1orf50 mRNA expression by in silico analysis based on data from TCGA stage II breast cancer patients (Fig. 1B). Here, C1orf50 is linked to breast cancer.